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Abstract: The consumption of a high-fat meal can induce acute postprandial lipemia 
(PPL) and endothelial dysfunction. We assessed the impact of age and physical activity 
on metabolic and vascular outcomes following meal consumption in healthy men and 
women. We recruited 4 groups of individuals: younger active (YA; age 22.1 ± 1.4 y; n = 
9), younger inactive (YI; age 22.6 ± 3.7 y; n = 8), older active (OA; age 68.4 ± 7.7 y; n = 
8), and older inactive (OI; age 67.7 ± 7.2 y; n = 7). Following a 10-hour overnight fast 
and 2 days of exercise avoidance, metabolic outcomes were measured at baseline and 
hourly for 6 hours after consumption of a high-fat meal (12 kcal/kg; 63% fat, 34% 
carbohydrate). Flow-mediated dilation (FMD) was measured at baseline, 2-hours, and 4-
hours post-meal. Total area under the curve (tAUC) for TG was significantly lower in the 
more active individuals but did not differ based on age (YA = 578.3 ± 120.5 mg/dL x 6 
hour, YI = 1032.0 ± 424.1, OA = 599.9 ± 235.3, OI = 1071.0 ± 149.5; p = 0.0004). FMD 
differed (p = 0.002) between groups at baseline (YA = 6.36 ± 1.70%; YI = 3.98 ± 1.67%, 
OA = 4.82 ± 1.27%, OI = 3.27 ± 1.33%), and decreased significantly in all groups 4 
hours after the meal (Mean diff: 1.19%; 95% CI: 0.27 to 2.11%). These findings highlight 
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Nutrition plays an essential role in determining the health condition of an individual. 
Health outcomes most commonly associated with poor nutrition are cardiovascular disease 
(CVD), type 2 diabetes, obesity, and certain forms of cancer (Kimokoti and Millen 2016). CVD 
accounts for 31% of all deaths globally (Stewart et al. 2017) and exhibits one of the strongest and 
most comprehensive connections with dietary behavior. A growing avenue of assessment with 
regard to nutrition and CVD risk is the postprandial metabolic response. Consumption of a single 
high-fat meal (HFM) results in a deleterious postprandial metabolic state that can include 
increased oxidative stress and inflammation (Jackson et al. 2012; Devaraj et al. 2008). The 
adverse metabolic response to a HFM is characterized by significantly elevated plasma 
triglycerides (TG), known as postprandial lipemia (PPL). The magnitude of this TG response is 
directly associated with CVD risk (Hyson et al. 2003) and is more strongly associated with CVD 
risk than fasting TG (Bansal et al. 2007). Given that most individuals likely spend the majority of 
their day in a postprandial state, PPL represents a more externally valid determinant of CVD risk. 
Age and physical activity are critical modifiers of PPL (Petitt and Cureton 2003; Gill and 
Hardman 2000), although most previous studies have investigated their effects separately. In a 
recent cross-sectional study by Emerson et al. (2018), the impact of both physical activity level 
and age on PPL were examined in younger active, older active, and older inactive individuals. 
This study found strong evidence that both aging and physical activity level modify the 




by older active individuals, and then younger active individuals. However, this study was limited 
in that it did not include a younger inactive group, therefore precluding determination of whether 
age or physical activity was a more important modifier of PPL. Nevertheless, findings from this 
study suggest that aging and physical activity level are important independent factors in 
determining the postprandial TG response, although the mechanisms through which age and 
physical activity modify PPL are not clear. 
Vascular function is another CVD risk indicator that is modified by nutrition, physical 
activity, and aging (Vogel 1997). Vascular function is primarily characterized by blood vessels’ 
ability to dilate and constrict appropriately in response to local and systemic stimuli. Vasodilation 
refers to the expansion of a vessel by the relaxation of smooth muscle cells that surround the 
endothelial lining. This is a natural homeostatic response to a lack of oxygen and allows for 
increased blood flow to peripheral tissues (Huang and Vita 2006). Vascular function is a logical 
diagnostic tool, given its vital role in maintaining physiological homeostasis and its association 
with CVD risk (Halcox et al. 2002). A prominent noninvasive strategy for measuring vascular 
function includes a technique known as flow-mediated dilation (FMD), determined via Doppler 
ultrasound (Green et al. 2011). FMD has found to be a strong predictor of CVD risk (Inaba et al. 
2010; Moens et al. 2005).  
Younger and more active individuals exhibit greater FMD in the fasted state compared to 
their older and less active counterparts (Dawson et al. 2013; de Groot et al. 2006; Parker et al. 
2006). However, little is known about how age and physical activity modify FMD after the 
consumption of a HFM. Most individuals in Western society spend the majority of the day in a 
continuous postprandial state; therefore, it is arguably more pragmatic to study vascular function 
after the consumption of a meal. To our knowledge, no previous studies have investigated the 
postprandial FMD response to a HFM in younger versus older individuals with different 




The purpose of this study was to assess the impact of age and physical activity on 
postprandial metabolism and vascular function. We hypothesized that there would be differences 
in postprandial TG and FMD responses based on age and physical activity level and that group 










Nutrition and Cardiovascular Disease 
Nutrition has been comprehensively studied for the role it plays in the development of 
CVD. Specifically, increased consumption of processed foods, saturated fat (SF), refined sugars, 
and sodium (Poti et al. 2015) have all been demonstrated to significantly increase CVD risk. 
Conversely, a reduction in nutrient-dense food consumption such as fruits and vegetables also 
increases the risk for CVD (Aune et al. 2017; Blanck et al. 2008). These changes in lifestyle 
choices have been coined as "westernization" and are rapidly expanding to other regions of the 
world undergoing similar changes (Pappachan 2011). Certain sources of SF (e.g. animal 
products) have been directly linked to increased incidence of CVD and are commonly 
incorporated into processed foods to increase shelf life (Siri-Turino et al. 2015). In a recent meta-
analysis reviewing 15 randomized controlled trials, Hooper et al. reported a 17% decrease in the 
risk of a cardiovascular event after incorporating a reduction of saturated fat. Additionally, 
sodium is liberally distributed throughout a vast array of foods to improve food longevity and 
palatability. The NHANES 2009-2012 analysis reported that nine out of ten Americans consume 
sodium in excess of the recommended daily upper limit (>2300 mg/day). Sodium has been linked 





Neal 2013). Similarly, commonly consumed processed foods contain high amounts of refined 
sugar, which on average comprises over 20% of total calories in processed foods, and is closely 
linked with metabolic syndrome. Over 80% of Americans consume above the recommended 10% 
of daily calories from refined sugars (Martinez et al. 2016). This link between disease and refined 
sugars is grounded in numerous meta-analyses and has become increasingly evident with the 40-
fold increase in sugar consumption since 1750 in the United States (Dinicolantonio et al. 2014; 
Bray et al. 2012). Intake of fruits and vegetables is markedly low, with 87% of Americans not 
meeting the daily intake requirements for vegetables, and 76% failing to fulfill the daily fruit 
consumption recommendations (Moore and Thompson 2015).  
Atherosclerosis is the product of poor dietary consumption and represents a major route 
to the development of CVD. Atherosclerosis is generally described as the progressive buildup of 
fat and cholesterol within arterial vessels and can lead to diminished vascular function or a 
cardiovascular event (Rafieian-Kopaei et al. 2014). Atherosclerosis causes nearly 50% of all 
deaths in the United States (Pahwa and Jialil 2018). Lipids are packaged and transported in the 
form of lipoproteins, such as low-density lipoprotein (LDL), that can contain high concentrations 
of cholesterol. These lipoproteins, particularly LDL, can penetrate the endothelium and become 
trapped and oxidized in the subendothelial space. Oxidized LDLs promote increased recruitment 
of macrophages, pro-inflammatory cytokines, and other immune cells, ultimately furthering 
intravascular plaque development (Mitra et al. 2011).  
Glucose can also have a negative effect on the endothelium and continuously high levels 
of blood glucose can lead to decreased insulin sensitivity. Insulin sensitivity allows cells to 
adequately utilize glucose and remove it from the circulation. Prolong elevated glucose levels and 
reduced insulin sensitivity are used as markers of disease risk. Hyperglycemia can disrupt normal 
cell signaling, disrupt hormonal regulation, and cause systemic inflammation promoting the 




Triglycerides (TG) are the primary form of lipid, both in the diet and in the human body. 
TG can be characterized into several different categories depending on their molecular 
morphology (e.g. saturated, unsaturated, trans). SF is defined by its hydrogenated nature, 
meaning it contains the maximum number of hydrogen atoms on each carbon. Foods high in SF 
include red meat, cheese, and butter. Unsaturated fats (e.g. polyunsaturated and monounsaturated) 
lack a hydrogen atom in the lipid molecule due to the presence of a double bond. Trans fats are 
naturally occurring lipids, but they are most commonly found in processed foods after undergoing 
partial hydrogenation. During the hydrogenation process, one or more double bond in a lipid 
molecule is replaced with the addition of hydrogen and re-configured in a trans formation. 
Saturated and trans fats have been found to be strongly associated with CVD (Nicholls et al. 
2006), while unsaturated lipids possess properties that reduce the risk of CVD (Keogh et al. 
2005). These dietary lipids differ with regard to their effects on CVD risk. High levels of serum 
LDL, TG, and cholesterol are strongly associated with an increased risk of CVD (Nelson 2013). 
SF reduces the LDL-receptor activity limiting LDL clearance capacity (Chiu et al. 2017). 
Unsaturated lipids have anti-inflammatory properties, which can potentially blunt the 
atherosclerotic process. An inverse association has been made with polyunsaturated fats and 
CVD, which can increase LDL receptor activity and attenuate LDL production (Siri-Tarino et al. 
2015). Most notably are polyunsaturated omega-3 fatty acids, eliciting some of the most 
pronounced health benefits. Poly and mono-unsaturated lipids are involved in anti-atherogenic, 
anti-inflammatory, inhibited platelet aggregation, anti-thrombotic, and arrhythmia prevention 
(Ander et al. 2003). 
Overall, poor nutrition is a major contributor to CVD, with nearly 70% of CVD attributed 
to poor lifestyle habits (Chieuve et al. 2008). Nutrition is a modifiable risk factor that can greatly 
reduce the risk of major chronic diseases. Dietary choices serve as an opportunity for individuals 





Physical Activity and Disease 
The American Heart Association recommends adults conduct at least 150 minutes of 
moderate aerobic exercise or 75 minutes of vigorous exercise, or an equivalent combination 
(Lobelo et al. 2018). Adults are also recommended to conduct full-body resistance training at 
least twice per week (Piercy et al. 2018). Westernized areas are characterized by low levels of 
physical activity, which is associated with excess body fat mass and numerous chronic diseases, 
including CVD (Zeng et al. 2012). Physical activity is considered one of the most accessible 
preventative measures of CVD, with nearly 12% of all myocardial infarctions associated with a 
lack of physical activity (Carnethon 2009). Exercise can also improve insulin sensitivity, helping 
to maintain glucose homeostasis and lower risk for cardiometabolic disease. Simply walking for 
30 minutes per day can reduce the risk of type II diabetes by 50% (Hamasaki 2016). Physical 
activity is also highly preventative for many types of cancer, with nearly 35% of cancer deaths in 
the United States attributed to a lack of physical activity. The reduction in cancer risk is 
commonly thought to be a result of decreased adiposity, reduced inflammatory markers, and 
increased regulation of growth factors that often accompanies higher levels of physical activity 
(Clague and Bernstein 2012). Increasing physical activity also improves cardiorespiratory fitness 
(CRF) and endothelial function, which are inversely associated with CVD, diabetes and all-cause 
mortality (Al-Mallah et al. 2018). Physical activity can beneficially modify cardiometabolic risk, 
and increasing physical activity is an accessible means of reducing risk disease (Vincent et al. 
2017). 
Postprandial Period and Cardiovascular Disease 
A growing avenue of assessment with regard to nutrition and CVD risk is the 
postprandial metabolic response. Individuals consuming large volumes of low-quality foods on a 
frequent basis are consistently evoking a deleterious postprandial metabolic state (Heden et al. 
2013; Klop et al. 2011; Waaler et al. 1991). This adverse metabolic state is characterized by 




several hours following high-fat feeding is characteristic of postprandial lipemia and the 
magnitude of this TG response is directly associated with CVD risk (Nelson 2013). In 
postprandial lipemia, there is enzymatic competition for serum lipids, resulting in saturation of 
clearance pathways, which leads to the deposit of the FFA within the endothelium (Nakamura et 
al. 2016). All the major organ systems, such as hepatic, renal, pancreatic, and digestive tract, are 
over time disrupted to some degree with large postprandial loads (Jacome-Sosa et al. 2016). 
Postprandial states also upregulate the expression of adhesion molecules (e.g. selectins and 
integrins), and increase the risk of cholesterol deposits in the vascular system which promotes 
atherosclerosis (Karpe 1999). High-density lipoproteins (HDL) are a primary component in the 
metabolic process of reverse cholesterol transport. Further, HDLs circulate in the bloodstream, 
attaching to extra-hepatic tissues in order to transport cholesterol back to hepatic systems for re-
utilization and excretion (Spady 1999). High levels of HDL are inversely related to 
atherosclerosis, whereas serum levels of LDL, TG, cholesterol, and glucose are positively 
correlated with disease risk (Shimokawa and Satoh 2014). Interestingly HDL levels have been 
found to decrease in the postprandial period, another example of the detrimental metabolic impact 
of large-volume, high-fat feeding (Alssema et al. 2010).  
These mechanisms through which a large postprandial metabolic response increases CVD 
risk are supported by the findings of cross-sectional and prospective cohort studies. Postprandial 
TG loads are the major driving force in the development of atherosclerosis and are positively 
associated with the progression of atherosclerosis (Teno et al. 2000). A prospective cohort study 
conducted by Bansal et al. (2007) assessed the association between fasting and non-fasting TG 
values in 26,509 healthy women. In this study, a blood draw was taken either fasted or non-fasted 
and the overall incidence of CVD was followed over 11 years. There was a stronger association 
with 2-4 hours postprandial TG and CVD risk (HR: 4.48 [1.98-10.15]) compared to the fasted (8-
12 hr) TG and CVD risk (HR: 1.31 [0.73-2.36]). Notably, after fully adjusting for confounding 




case-control study by Patsch et al. (1992) examined a postprandial TG in individuals with 
coronary artery disease (CAD; n = 61) and healthy controls (n = 40). A predictive model was 
created using fasted vs. postprandial metabolic outcomes in these participants to assess the 
absence or presence of CAD. Not only were postprandial TG significantly greater in the CAD 
patients, but the study revealed a greater ability to predict CAD with postprandial TG (83%) 
compared to using fasted TG values (68%). Thus, several lines of evidence support the notion 
that postprandial lipemia is highly influential with regard to CVD risk. 
Physical activity improves the uptake and utilization of serum TG and glucose, which 
attenuates endothelial damage caused by a meal (Emerson et al. 2018). In a cross-sectional study 
by Braxton and colleagues (2018), the postprandial TG responses of 671 healthy individuals were 
assessed following a high-fat meal and compared to their overall physical activity level. Activity 
was measured continuously using accelerometers worn by participants for 7 days. Total area 
under the curve (tAUC) TG responses were significantly lower in individuals with high levels of 
activity (p = 0.003) after controlling for age, sex, BMI, and fasting LDL. In this study, individuals 
in the highest quartile of habitual physical activity exhibited a 17% lower postprandial TG 
response compared to individuals in the lowest quartile of physical activity. Acute and habitual 
physical activity are both shown to increase the uptake and utilization of the deleterious 
byproducts of meal intake in numerous prospective cohort and controlled trials (Homer et al. 
2017; Freese et al. 2013). 
It is likely that age is also an important modifying factor in postprandial lipemia. In a 
recent cross-sectional study by Emerson et al. (2018), the impact of physical activity and age on 
postprandial responses was examined. Healthy individuals were separated into 3 groups differing 
in physical activity and age, including eight young active adults (YA: age 18-35 years; 4M/4W), 
eight older active adults (OA: age 60+ years; 4M/4W), and six older inactive adults (OI: 3M/3W). 
Metabolic outcomes (e.g. Glucose, HDL, LDL, TG) were compared after the consumption of a 




(p = 0.0002). Additionally, the OA TG tAUC was significantly lower compared to the OI TG 
tAUC (p = 0.02). Thus, this study found evidence that both aging and physical activity level 
modify the postprandial TG response, with younger and more active individuals generally 
exhibiting a lesser response to a high-fat meal. However, this study was limited in that it did not 
include a younger inactive group and did not address mechanisms of difference between groups. 
Nevertheless, data to this point suggest that aging and physical activity level are important factors 
in determining the postprandial metabolic response, which is associated with CVD risk. 
Vascular Function 
 Vascular function is the plexus of physiological systems that allows an adequate supply 
of blood throughout the body to maintain physiological homeostasis (Sandoo et al. 2010). The 
heart is the primary mechanical driver in the circulatory system. Vessels are comprised of three 
layers: the tunica intima, tunica media, and tunica adventitia. The tunica intima is the innermost 
lining of the vessel and is also known as the endothelium, which mediates changing vessel 
conditions (Pearson 2000). The blood that is distributed within this system acts as the carrier for 
blood gases, enzymes, hormones, and nutrients. The vascular system is most commonly 
delineated into two major systems: the arterial and venous systems. The arterial system is 
comprised of vessels (arteries and arterioles) that carry oxygenated blood from the heart toward 
peripheral tissues. Conversely, the venous pathway directs deoxygenated blood back to the heart 
where it can become re-oxygenated via the pulmonary tract (Dela Paz and D’Amore 2009). Both 
of these circulatory systems work concertedly to provide the tissues of the body with a sustained 
supply of oxygen and facilitate normal cellular function (Pugsley and Tabrizchi 2000).  
 Blood vessels are not only important with regard to blood flow distribution and oxygen 
delivery, but they also play a critical role in the development, prevention, and recovery of 
diseases. Physical and cognitive development requires constant replenishment of nutrients that are 




Additionally, the endothelial lining acts as the surface where nutrient exchange occurs. 
Individuals who develop negative structural adaptations such as the development of plaque and 
increased vessel wall thickness exhibit diminished nutrient uptake potentially hindering cell 
growth and repair (Kusters and Barrett 2016). From a disease standpoint, deterioration of vascular 
health is a critical element in the development of CVD, diabetes, and cancer. Individuals who 
engage in unhealthy lifestyle behavior (e.g. alcohol abuse, obesity, smoking, poor diet, exercise) 
often first experience an impairment in vascular function which further promotes the cascade of 
disease (Odegaard et al. 2011). 
  Vascular function is largely characterized by the vessels’ ability to vasodilate and 
constrict properly in response to local and systemic stimuli. Vasodilation is a critical element in 
providing adequate blood flow to specific regions throughout the body and is a natural 
homeostatic response to a lack of oxygen. This response propagates the relaxation of smooth 
muscle cells that compose the endothelial lining (Huang and Vita 2006). A lack of blood flow or 
excess constriction increases the frictional drag within a vessel – this biomechanical metric is 
known as shear stress. Shear stress is a potent stimulus for the cellular release of nitric oxide, 
which is the primary agent in relaxing smooth muscle cells to allow vessel dilation (Lu and 
Kassab 2011). Conversely, vasoconstriction is a physiological response that is characterized by 
vessels narrowing. Vasoconstriction is also mediated by vasoactive compounds (e.g. endothelin, 
angiotensin II, and epinephrine) to help regulate items such as heat loss, stress, and blood 
pressure (Thompson-Torgerson et al. 2008). Over time, vessels naturally lose elasticity to a 
certain degree, promoting arterial stiffness. A lack of arterial distensibility is directly related to 
the ability of the body to accommodate to physiological pressure changes, thus prolonged 
diminished function can elicit damage throughout the entire arterial tree (Cecelja and 
Chowienczyk 2012). An increase in arterial stiffness is an independent predictor of CVD risk 




muscle cells to accommodate changing environmental conditions. Impaired dilation or 
constriction can exacerbate underlying disease conditions that require vascular adaptability. In the 
case of atherosclerosis, hardening of the arterial vessels from lipid accumulation also decreases 
vessel distensibility (Haluska et al. 2010). Arteries eventually can accumulate sufficient plaque to 
impair blood flow and vasodilation. Plaque can lead to a cardiovascular event such as a stroke, 
myocardial infarction, or cardiac arrest. This outcome remains difficult to prevent due to the 
highly asymptomatic nature of the vascular disease progression (Lauer 2010). 
Vascular function is a logical diagnostic tool, given its vital role in maintaining 
homeostasis and its association with various health conditions (Halcox et al. 2002). There are 
several clinical methods for measuring the functional ability of the vascular system. 
Categorically, these can be thought of as invasive or non-invasive strategies (Al-Qaisi et al. 
2008). Invasive strategies include biopsy operations, coronary angiography, or the infusion of 
vasoactive compounds (e.g. Acetylcholine, Nitroglycerine, or Adenosine) to elicit a vascular 
response (Petersen et al. 2014; Kuvin et al. 2001). Noninvasive strategies include magnetic 
resonance imaging (MRI) and flow-mediated dilation (FMD) techniques via Doppler ultrasound. 
MRI and Doppler ultrasound techniques are often used to provide an external image of how 
vascular dimensions compare to healthy individuals and a vessel’s capacity to adequately supply 
blood flow. Lastly, FMD via Doppler ultrasound provides a stress stimulus by occluding a 
portion of the body or by voluntary muscular contraction (i.e. handgrip), and determining the 
dilatory response to increased blood flow (Flammer et al. 2012).  
 Indirect measurements of vascular health are more frequently used to evaluate an 
individual’s risk for disease or a disease state. Metabolic markers such as blood pressure, glucose, 
HDL, LDL, TG, and cholesterol are highly correlated markers of vascular health (Montgomery 
and Brown 2013). These biomarkers are indicative of the physiological conditions that the 




status. Other biomarkers, such as reactive oxygen species (ROS) represent levels of oxidative 
stress, which can promote atherosclerotic cascades (He and Zuo 2015). ROS can actively promote 
endothelial damage leading to low-grade inflammation and the release of cytokines. 
Inflammatory markers such as C-reactive protein (CRP), tumor necrosis factor alpha (TNF-α), 
interleukin-1 (IL-1), and vascular cell adhesion molecule-1 (VCAM-1) are standard makers used 
for gauging overall levels of inflammation (Hall et al. 2013). Additionally, deteriorating vascular 
health has been linked to chronically increased levels of angiogenic substances (Shibuya 2006). 
These growth factors play an integral role in the production of new red blood cells to supply more 
oxygen in surrounding tissues. Markers such as vascular endothelial growth factor (VEGF), 
Angiopoietin, bone morphogenic protein 9 (BMP-9), epidermal growth factor (EGF), Endoglin, 
Endothelin-1, and fibroblast growth factor 1 (FGF-1) are regularly recognized agents involved in 
angiogenesis and indirect indicators of vascular health (Nashida et al. 2006). Elevated levels of 
these substances are common in disease states, wound healing, or tumor development. However, 
prolonged elevated levels can cause pathogenic hyperpermeability of vessels and potentially 
impair the ability of the vascular system to drain waste, nutrients, and water properly (Nagy et al. 
2008). Lastly, high levels of these angiogenic molecules can exacerbate the development and 
growth of certain cancerous tissues (Carmeliet et al. 2000). 
Flow-Mediated Dilation 
Flow-mediated dilation is the natural dilatory response of vessels to an increase in local 
blood flow. This dilatory response is produced from the release of nitric oxide (NO) in 
endothelial cells (Bian et al. 2008). Items such as platelet aggregation, cellular proliferation, and 
the development of adhesion molecules can be blunted by the release of NO, which allows 
relaxation of smooth muscle cells (Bruno et al. 2014). The inability to dilate vessels (i.e. a lower 
FMD response) can, over time, lead to detrimental vascular remodeling and increase damage to 




stimulate a NO-dependent dilatory response is considered an indicator of vascular health (Cannon 
1998). The first FMD assessments were explored in 1992 by Celermajer and colleagues as a non-
invasive procedure to detect endothelial dysfunction in children and adults (Celermajer et al. 
1992). Individuals with familial hypercholesterolemia, smokers, and those with coronary artery 
disease expressed a greatly reduced or absent dilatory response. Many studies have built on this 
seminal work, and over time there has been widespread adoption of FMD as an assessment tool 
for vascular function. In a recent meta-analysis (Ras et al. 2013) comprised of 14,753 subjects, 
FMD was inversely associated with the incidence of CVD with a relative risk of 0.92 (95% CI: 
0.88; 0.95) per 1% higher FMD. Another meta-analysis in 2005 by Witte et al., reviewed 211 
FMD studies and found a 1.42% decrease in FMD for every 1% increase in Framingham risk, 
which is a gender-specific 10-year risk scale for developing cardiovascular disease. These 
findings support the conclusion that FMD is proportional to individual CVD risk. Due to the 
close relationship between vascular function and CVD development, examining vascular biology 
via FMD is an underutilized metric for the development, progression, and diagnosis of 
cardiometabolic diseases (Shechter et al. 2009; Yeboah et al. 2009). 
Overview of Flow-mediated Dilation Protocol 
FMD has been used in a variety of studies and follows a fairly consistent protocol (for 
reviews see Alley et al. 2014; Harris et al. 2010; and Corretti et al. 2002). An FMD assessment 
begins with an individual laying in a supine position for 5-20 minutes in a dark space to acclimate 
to the environment (Thijssen et al. 2011). FMD trials then typically incorporate occlusion of an 
extremity that falls in close proximity to a large conduit artery. For example, occlusion of the 
forearm/wrist and analyzing the proximal brachial artery is common. Before beginning occlusion, 
baseline measurements of the artery diameter are measured for roughly 1-2 minutes. Occlusion is 
induced by placing a blood pressure cuff at a point distal to the given artery to deprive tissues of 




then deflated, allowing a hyperemic response to occur. This large amount of blood volume 
increases the shear stress in the vessel, eliciting the release of NO, and causing dilation of the 
artery. During the entire procedure, the brachial artery is being imaged via duplex ultrasound to 
capture a grayscale image of the chosen vessel, through which the dilatory changes can then be 
assessed. The vessel diameter change that occurs during this acute period of hyperemia (after cuff 
deflation diameter) is known as the FMD% and is the primary outcome of interest. Shear stress is 
thought of as the amount of frictional drag caused on the walls of the vessel and is directly 
proportional to the viscosity and velocity of blood within the vessel (Pyke and Tschakovsky 
2005). Transiently increased levels of shear stress are a major driver of FMD responses (Padilla et 
al. 2008; O’Rourke and Nichols 2004). A larger FMD response is considered reflective of more 
optimal vascular health. Healthy individuals with no ongoing chronic disease will often exhibit an 
FMD between 8-15% (Weissgerber 2014). Unhealthy individuals experience diminished FMD%, 
and those with existing CVD can exhibit an FMD% < 5% (Maruhashi et al. 2013).  
Factors that Influence Flow-mediated Dilation 
Many factors can influence the FMD response, including individual-level factors such as 
gender, disease states, physical activity, age, and medications, as well as variability associated 
with the technique itself. To help control for some of these sources of variability, subjects are 
typically fasted and have abstained from caffeine and alcohol for at least 8-24 hours prior to the 
assessment (Noguchi et al. 2015). Exercise also has an acute negative effect on the FMD 
response, so research subjects are typically instructed to refrain from strenuous exercise for 24-48 
hours prior to data collection (Currie et al. 2012). FMD responses have been previously shown to 
be influenced by the time of data collection as well (i.e. increases from 2:00 PM until peaking at 
2:00 AM). Physiological conditions related to FMD have a tendency to remain elevated in the 




most trials are executed during a consistent time window in the morning hours to limit these 
effects (Padilla et al. 2007).  
Gender is often an important factor to consider when studying FMD because of the well-
known physiological differences between men and women. FMD for premenopausal women is 
typically adjusted to account for potential hormonal variation (Hashimoto et al. 1995). Females 
exhibit cardiovascular protective hormones such as estrogen and progesterone to a greater extent 
than males, which is suggested to result in a greater FMD response in females (Pérez-López et al. 
2010). Males generally have more muscle mass and increased arterial size. The size of the artery 
has been suggested to influence the FMD response, where larger arteries exhibit a lesser dilatory 
response (Mizia‐Stec et al. 2007; Paradossi et al. 2004; Celermajer et al. 1992).  
Pharmacological influences are some of the most potent regulators of FMD. Medicine is 
often prescribed to enhance the dilatory response in individuals at risk for a CVD event to prevent 
the detrimental effects of vascular remodeling. Hypertensive medications such as diuretics, beta-
blockers, ace inhibitors, and vasodilators are common within westernized society to help mitigate 
vascular resistance, albeit through different mechanisms (Ghiadoni et al. 2003). Cholesterol-
lowering drugs are also prescribed from a preventative standpoint due to the prevalent nature of 
hypercholesterolemia in the United States. As previously mentioned, cholesterol plays a crucial 
role in the atherosclerotic process. Therefore these medications have a direct relationship with 
FMD (Takenaka et al. 2013). Lastly, over-the-counter medications, such as aspirin, can modify 
blood viscosity, thus potentially altering FMD (Magen et al. 2005). In a 2011 study by Furuno et 
al., brachial artery FMD exhibited a positive dose-dependent response with the intake of aspirin 
with intake between 80-660 mg; however, FMD begins to worsen with intake above 660 mg/day. 
Complete abstinence from medication may not be permissible with all populations, but the 




Other factors to consider in FMD data collection are inter- and intra-experimenter 
variability. In this context, intra-experimenter variability is designated for variability within an 
individual researcher, whereas inter-experimenter variability refers to the variability between 
different researchers when analyzing the same data (Marietta et al. 2010). Each form of 
variability is quantified by calculating the inter- and intra-collection coefficient (ICC). Overall, 
variability is minimized by maintaining the consistency of experimenters and methods throughout 
data collection. ICC variability for intra- and inter-experimenter variability has been reported to 
be 0.84-0.99 and 0.82-0.87, respectively, with trained sonographers (Charakida et al. 2013). 
Additionally, data should be void of names or specific labels and analyzed randomly to minimize 
bias introduced from the experimenter's perspective. Variations in cuff placement can also prompt 
different mechanistic dilatory responses. Placement of the cuff distal to the artery is found to 
create the most prominent NO response and have less physical influence on the tissues being 
analyzed (Ghiadoni et al. 2015; Betik et al. 2004). Further, when comparing different cuff 
placements, wrist cuff occlusion has been associated more closely with CVD risk (Doshi et al. 
2001). Magnitude and duration of occlusion also independently modulates FMD outcomes. 
Occlusion is found to be effective at roughly 25-50 mmHg above an individual’s systolic blood 
pressure for a duration of 5-10 minutes (Uehata et al. 1997). Other mechanisms outside of NO 
have been noted to become more active beyond the 5-minute occlusion window (Harris et al. 
2010). Studies have demonstrated that, when meticulously executed according to protocol, FMD 
assessments can produce valid and reproducible data, despite the risk of experimenter error 
(Simova et al. 2008).  
Nutritional Impacts on Flow-Mediated Dilation 
 Nutritional factors such as sodium, antioxidants, alcohol, protein, glucose, and lipids have 
been shown to alter FMD or be associated with certain FMD patterns. Sodium is an important 




(Farquhar et al. 2015). However, the amount needed in the diet to sustain adequate function is 
vastly different from the mean average sodium intake in the US diet (500mg vs. 3200mg). 
Sodium in excess has a well-known relationship with the development of hypertension (Ha 2014 
and Aronow 2017). Irregular blood pressure and fluid dynamics due to excess sodium can 
consequently affect FMD in an adverse manner. Specifically, sodium elicits a decrease in FMD 
independently of blood pressure. In 2015, Mathews et al. measured FMD in a controlled feeding 
study where individuals (n = 20) consumed a 7-day high-salt diet (HS) or a 7-day low salt diet 
(LS). In this study, 10 individuals were determined to be salt-sensitive (SS; age 39 ± 5 yr; 5 men, 
5 women), and 10 individuals were salt-resistant (SR; age 42 ± 5 yr; 5 men, 5 women). FMD was 
significantly lower in the HS diet compared to the LS diet (FMD: SR LS 10.6 ± 1.3%, SR HS 7.2 
± 1.5%, SS LS 12.5 ± 1.7%, SS HS 7.8 ± 1.4%). Interestingly, there was no significant difference 
between SR and SS, thus supporting the adverse effect of sodium on FMD independent of blood 
pressure. A decreased FMD from chronic salt consumption is proposed because dietary sodium 
causes a concomitant superoxide response (ROS), and suppression of angiotensin II, which 
decreases SOD expression (Edwards and Farquhar 2015). Extracellular levels of sodium can also 
induce increased secretion of aldosterone which can lead to endothelial stiffness and decreases 
NO secretion. Thus, long-term excess sodium consumption plays an integral role in diminished 
vascular function and decreases FMD ability in individuals (Dickinson et al. 2009).   
Dietary protein also has the potential to modify FMD. Inadequate protein intake is 
associated with a decrease in serum arginine availability, which is used in the synthesis of NO. 
Thus, individuals who acquire a protein deficiency may have an impaired ability to produce a 
NO-mediated FMD response (Luiking et al. 2010). Protein sources such as red meat, processed 
meat, and dairy are positively associated with CVD. Conversely, plant sources of protein, such as 
soy, nuts, and beans, have an inverse relationship with CVD (Micha et al. 2012). Many of these 




extensively studied with regard to FMD, and consumption of soley protein sources is not 
common in a typical western diet. Protein constitutes a small portion of the overall diet, and the 
impact of chronic high protein consumption on vascular function has yet to be studied. 
Some variation in the FMD response can be explained by the intake of vitamins and 
minerals (Plantiga et al. 2007). With respect to vitamins, the most common mediators of 
endothelial function include vitamins C, E, and A. Vitamins C, E, and A actually increase the 
release of NO within vessels. Additionally, these act as potent antioxidant agents which can 
mitigate cellular ROS production. Antioxidants remain one of the primary agents in fruits and 
vegetables that improve the diet. It has been demonstrated that supplementation of fruit, 
vegetables, or an oral antioxidant vitamin supplement can improve FMD responses (Varadharaj et 
al. 2017; Khan et al. 2014; Esposito et al. 2003).  
The important dietary minerals concerning FMD include calcium, iron, and magnesium. 
Normal cellular levels of calcium can improve the synthesis and release of NO within the 
endothelium. However, calcium supplementation in excess has been associated with an increase 
in cardiovascular morbidity and arterial calcification (Anderson et al. 2016). Iron plays a critical 
role in the production of NO and can ultimately affect the expression of NOS. Once ingested, iron 
improves the mRNA expression of NOS2 which is the primary producer of NO (Nairz et al. 
2013). Magnesium is a potent vasorelaxation mineral and has a positive dose-dependent NO 
response. Magnesium is a cofactor for acetylcholine-induced vessel relaxation, and even subtle 
alterations in extracellular magnesium can elicit a dilatory response. Further, magnesium 
supplementation has been associated with improved FMD responses in healthy individuals and 
those with CVD-related conditions (Rosique-Esteban et al. 2018). Barbagallo et al. (2010) 
conducted a magnesium supplementation intervention in which the elderly (>65 years) 
individuals with pre-existing diabetes and hypertension consumed 368mg/day for one month. 




p < 0.05), whereas no significant difference was found in the control group. Overall, intake levels 
of certain vitamins and minerals can influence vascular function and FMD. 
Another nutritional perspective not commonly considered for FMD is alcohol 
consumption. Alcohol has acute benefits with regard to dilatory responses in healthy individuals 
(Vlachopoulos et al. 2003). The primary cardioprotective mechanism behind alcohol is thought to 
be prompted by the decrease in plasma fibrinogen levels, platelet aggregation, and an increase in 
NOS stimulation (Vlachopoulos et al. 2003). Certain beverages, such as wines, contain active 
phenolic compounds as a derivative of plant products used in the fermentation process. Drinks 
containing polyphenol substances are more likely to exhibit a beneficial FMD response due to 
their antioxidative properties (Barona et al. 2012). However, these beneficial responses likely do 
not outweigh the other detrimental effects of consuming alcoholic beverages. Alcohol 
consumption induces the production of superoxide anions (ROS) that can ultimately cause 
endothelial inflammation. Intake beyond the recommended daily allowance (>2 drinks/day in 
men and 1 drink/day in women) has been associated with a decrease in endothelial function 
(Suzuki et al. 2009).  
Postprandial Flow-Mediated Dilation  
Meal-induced elevations in glucose and TG can impair vascular function. Frequent meal 
consumption increases the duration that the circulatory system remains in this deleterious state. 
Elevated levels of lipids in circulation inhibit normal cell signaling, promotes adhesion molecule 
production, and can exacerbate atherogenesis (Jagla and Schrezenmeir 2001), ultimately leading 
to an impaired FMD response. In a study done by Vogel et al. in 1997, FMD was examined in the 
postprandial period each hour over a 6-hour period after a high- and low-fat isocaloric meal 
(900kcal). Interestingly, the high-fat meal decreased FMD from 21 ± 5% at baseline to 11 ± 4%, 
11 ± 6%, and 10 ± 3% at 2, 3, and 4 hours after the high-fat meal, respectively. However, no 




significantly correlated with FMD responses (p = 0.02), suggesting a strong connection between 
postprandial lipemia and FMD. 
From a postprandial perspective, protein can be beneficial because of its ability to delay 
gastric emptying. This concept was recently demonstrated in a study by Phillips et al. 2014, 
where participants consumed either a high-fat meal (HF; fat content: 0.35g/kg, no protein), high 
fat + low protein meal (HFLP; fat content: 0.35g/kg, protein content: 0.18g/kg), or a high fat + 
high protein meal (HFHP; fat content: 0.35g/kg, protein content: 0.36g/kg). FMD measurements 
were taken at baseline and 60 minutes after completion of the meal. They found that the HF (-
3.8% ± 1.9; p = 0.01) FMD was significantly lower than the HFLP (+1.5 ± 0.8%; p = 0.98) and 
HFHP (+1.7% ± 1.3; p = 0.79) There were no significant differences between HFLP and HFHP 
(p = 0.79). Thus, protein can play a role in blunting some of the negative FMD effects of a HFM 
meal. 
Glucose provides the sustained fuel source for cells throughout the body but can be 
detrimental to vascular function at high levels. Most pronounced in individuals with type II 
diabetes, hyperglycemia is characterized as a major suppressor of FMD. The majority of clinical 
glucose measurements occur in a fasted state, while most negative hyperglycemic effects occur in 
the postprandial period (Kawano et al. 1999). These high concentrations of glucose after the 
consumption of a meal provoke ROS production within the endothelium, which can prevent or 
counteract vasodilation (Bonnefont-Rousselot 2002). As serum glucose levels rise following the 
consumption of a meal, there is also a consequential rise in insulin in a healthy individual. 
Subjects who have impaired insulin sensitivity can experience prolonged levels of serum insulin. 
High levels of insulin prevent insulin-dependent vasorelaxation, and acetylcholine-induced 
vasorelaxation (Hwang and Lee 2016). Acutely, high levels of serum glucose promote vessel 
shear stress leading to an increased vasodilatory response necessary for cellular uptake of glucose 




dilatory action. In addition to the desensitization of vasodilatory substances, chronic 
hyperglycemia can induce the production of vasoconstrictive biomarkers such as thromboxane, 
thus decreasing FMD (Xiang et al. 2007). Hyperglycemia overloads the glycolytic pathway 
which can obstruct NO synthase activity from occurring properly and increases the expression of 
pro-inflammatory cytokines. Hyperglycemia has also been found to reduce FMD via increases in 
lipid peroxidation, further supporting the role of fat in vascular dysfunction (Mah et al. 2011). 
Excessive lipid breakdown fuels superoxide radical production, which compromises NO 
bioavailability. In a recent review by Wallace and colleagues in 2010, 20 studies were analyzed 
for postprandial FMD interactions, reporting a strong association between decreased FMD in 
postprandial states. However, very few studies have assessed components such as age and 
physical activity in the experimentation of postprandial FMD. 
Physical Activity and Flow-Mediated Dilation  
Physical activity is an important determinant of overall health. Exercise can transiently 
reduce free radical damage by engaging protective myocardium mnSOD activity (Golbidi 2012). 
Similarly, exercise also can cause a short-term pro-inflammatory state, with the upregulation of 
items such as IL-6, TNF-α, and CRP. However, this is met with a more pronounced long-term 
anti-inflammatory response that reduces detrimental markers (Kasapis et al. 2005). Physical 
activity also increases the expression of eNOS, which stimulates NO production. Further, a bout 
of exercise can also help maintain an optimal balance between angiogenic and angiostatic 
phenotypes (Golbidi et al. 2011). Thus, physical activity can modify vascular function and FMD 
outcomes, although several factors influence this relationship, such as the type of exercise, 
frequency, and intensity.  
Exercise is commonly referenced into two large categories: resistance training and aerobic 
training. Resistance training is the process of providing progressive overload to skeletal muscles 




strength and mass. Skeletal muscle mass is largely involved in the process of glucose and TG 
metabolism (Jensen et al. 2011). Thus, resistance exercise can influence both body composition 
and macronutrient metabolism (Bea et al. 2010). In relation to endothelial function, resistance 
exercise can improve FMD responses. In a recent randomized controlled trial, a 10-week 
resistance training intervention with healthy individuals improved FMD from 8.5% to 9.8%. 
Individuals in this study conducted resistance training twice a week for approximately 70 minutes 
(Yu et al. 2016). The improvements in vascular function provided from resistance training make 
it a potential component in the prevention of CVD.  
Aerobic exercise refers to an activity that requires oxygen and typically involves 
rhythmic activities such as running, cycling, and swimming. Aerobic training is associated with 
large improvements in FMD responses. A study in 2011 by Kwon et al. reviewed the differences 
in FMD improvements in overweight women with T2DM (n = 40) after 12 weeks of being in one 
of three groups: aerobic exercise group (AEG), resistance exercise group (REG), or a control 
group (CG). The AEG experienced significantly greater FMD improvements after the exercise 
intervention (2.2% ± 1.9%; p < 0.05) compared to the REG (0.7% ± 3.6%; p = 0.535) and CG (-
0.7% ± 2.8%; p = 0.365). This has been reproduced in other studies as well as supporting the 
notion that aerobic training may produce more beneficial effects on endothelial health than 
resistance training (Black et al. 2008; Desouza et al. 2000).    
Physical activity is greatly involved in the reduction of risk for many diseases. The 
impact of frequency, intensity, duration, and exercise type all remain influential modalities of 
disease risk. Although each type of exercise (i.e. anaerobic or aerobic) contains independent 
benefits, the most beneficial program contains a combination of the two (Ho et al. 2012). The 
benefits of physical activity include reduced inflammation, and improved body composition and 




relation to FMD responses. Overall, physical activity and exercise remain excellent avenues 
through which to improve vascular function and FMD. 
Age and Flow-Mediated Dilation 
Vascular function generally decreases with age due to many different biological 
processes. Decreased NO bioavailability is thought to be a result of reduced production of 
tetrahydrobiopterin (BH4) synthesis, which is a cofactor for NO production (Pierce and LaRocca 
2008). As individuals age, they are exposed to detrimental vascular markers for a longer period of 
time. In addition to postprandial metabolic markers, items such as inflammatory markers, ROS, 
and angiogenic compounds have had more time to inflict damage upon the endothelium. Smooth 
cell function is also thought to play a role in the decrement of aging vascular function (Al-Shaer 
et al. 2006). Pro-constrictors such as endothelin-1 become upregulated with aging, thus causing 
unnecessary arterial constriction (Thijssen et al. 2006). These impairments stand in clear contrast 
with the vascular function of younger individuals. Younger individuals rarely experience 
impaired nitric oxide production and dilatory responses. Age-related decline in FMD generally 
does not begin until age 40 years in men and 50 years in women (Celermajer et al. 1994). This 
age-related decrement in FMD is thought to partially be a derivative of arterial stiffening, 
enlargement of arterial diameter, and the thickening of the intima-media in older individuals 
(Nagai et al. 2013). Additionally, postmenopausal women experience a sharp decrease in FMD 
due to the reduction of estrogen production (Moreau et al. 2012). Nonetheless, FMD is a strong 
independent predictor of CVD within older individuals (Yeboah et al. 2008). In a recent meta-
analysis, Montero et al. 2014 reviewed 530 long-term athletes (452 endurance-trained, 49 
strength-trained, and 29 endurance- and strength-trained) to cross-sectionally establish the 
different FMD responses in young athletes compared to older athletes. Interestingly, the younger 
athletic individuals exhibited an FMD similar to their control (p = 0.22), while older athletic 




suggests that the benefits of exercise with regard to FMD may be age-dependent. However, this 
finding could also be due to an already adequate FMD response in the younger population. Aging 
individuals also generally experience a decreased ability to conduct physical activity along with 
an increased risk of skeletal muscle injury, cardiovascular events, and an increased risk of falling 
(Bird et al. 2013). Overall, it is important to understand the relationship between aging, physical 
activity, and FMD. Moreover, a balance between exercise, diet, and vascular function 
improvement must be identified to explore new avenues of CVD prevention.  
Purpose and Hypotheses 
Despite a large amount of literature investigating FMD, there is limited data focusing on 
aging individuals. Age-related decline in FMD could be explained by several mechanisms, 
including increased systemic inflammation, oxidative stress, and impaired metabolic clearance 
(e.g. Glucose, TG). However, these outcomes can also be modified by lifestyle factors, such as 
diet and physical activity. Additionally, many previous studies analyzed FMD in a fasted context. 
However, given that most individuals in Western society spend the majority of the day in a 
continuous postprandial state, it is arguably more pragmatic to study vascular function after the 
consumption of a meal. No previous studies have investigated the postprandial FMD response to 
a high-fat meal in older adults. In addition, the influence of regular physical activity in modifying 
the relationship between aging and postprandial vascular function has not been studied.  
 Therefore, the purpose of this study is to determine the impact of age and physical 
activity level on postprandial metabolism and vascular function. This study will assess fasting and 
postprandial metabolic (Glucose, TG) and vascular (FMD) responses in groups that differ by age 
and physical activity level. Specifically, this will involve four groups of individuals: younger 
active (YA), younger inactive (YI), older active (OA), and older inactive (OI) adults. A secondary 
purpose is to elucidate potential mechanisms explaining postprandial differences between groups. 




responses based on age and physical activity level, with younger and more active individuals 
exhibited better metabolic and vascular function outcomes 2) Group differences in postprandial 










Participants were recruited based on age (younger: 18-35 years; older: 60+ years) and 
physical activity level (i.e. active and inactive). Participants were classified as active if they met 
physical activity guidelines (Piercy et al. 2018), which was defined as ≥150 minutes per week of 
moderate-intensity physical activity or ≥75 minutes per week of vigorous-intensity physical 
activity, or some equivalent combination. Individuals were classified as inactive if they did not 
meet physical activity guidelines and engaged in <30 minutes of planned exercise each week. 
Participants were also excluded from the study if their physical activity habits had changed 
significantly within the past 5 years. A medical history questionnaire was also administered to 
ensure individuals did not have any ongoing chronic disease, were not currently taking lipid-
lowering or hypertensive medication, and were not consuming tobacco products. This study was 
approved by and conducted in accordance with the guidelines and regulations of the Oklahoma 
State University’s Institutional Review Board. 
Initial Assessment 
Individuals recruited for this study completed an initial assessment to record 
anthropometrics, complete questionnaires, and receive experimental instruction. Height was 




Weight and body composition were assessed using a combination of digital scale and 
bioelectrical impedance analyzer (Seca mBCA 514; Seca GmbH; Hamburg, Germany). Blood 
pressure was measured using an automatic blood pressure cuff (Omron 5 Series BP742N; Omron; 
Kyoto, Japan). We then conducted an extensive interview with each participant to determine their 
regular physical activity level. Afterward, each participant wore a wrist-based accelerometer 
(wGT3X-BT; Actigraph LLC; Pensacola, FL) to confirm appropriate physical activity group 
placement. Activity trackers were placed on the non-dominant wrist and recorded activity data for 
5 days prior to the main assessment.  
Meal Tolerance Test 
Based on their scheduling availability, participants selected a time to begin the meal 
tolerance test between 0500-0900 hours. Participants were instructed to refrain from exercise for 
48 hours prior to their test and caffeine consumption on the day of the experiment. Participants 
were given a small pre-packaged snack (Peanut butter crackers 230 kcal; Snyder’s-Lance, Inc.; 
Charlotte, NC) to consume prior to initiating a 10-hour fast, in order to ensure that all participants 
were similarly fasted prior to the HFM.  
Upon arriving in the laboratory, an indwelling 24-gauge safelet catheter (Exel 
International; Redondo Beach, CA) was inserted into a forearm vein and a slow infusion of 0.9% 
NaCl was initiated. Tegaderm film (3M Healthcare; Neuss, Germany) was placed over the 
insertion region to prevent dislodgement of the catheter. A baseline blood sample was collected, 
after which the HFM was given to the participant with a completion time limit of 20 minutes. We 
chose to use chocolate pie as our HFM to reflect a realistic food item (Marie Callender’s 
Chocolate Satin Pie; Conagra Brands; Omaha, NE, USA; 12 kcal/kg body weight; 63% fat, 34% 
carbohydrate). We have utilized this HFM to elicit a PPL response in a previous similar study 
(Emerson et al. 2018). Water was available ad libitum with the meal and during the post-meal 




taken each hour to measure postprandial TG, glucose, total cholesterol (Total-C), high-density 
lipoprotein cholesterol (HDL-C), and low-density lipoprotein cholesterol (LDL-C) via Cholestech 
LDX analyzer (Alere Cholestech; San Diego, CA). For each blood draw, a 3 mL syringe (BD; 
Franklin Lakes, NJ, USA) was used to remove saline from the line, after which the actual blood 
sample was drawn into a 5 mL syringe (BD; Franklin Lakes, NJ, USA). The 5 mL syringe was 
then emptied into a 6 mL vacutainer test tube (BD; Franklin Lakes, NJ, USA) coated with EDTA. 
For lipid analysis, approximately 40 μL of whole blood was drawn into a capillary tube and 
placed in a Cholestech cassette and then inserted into the Cholestech LDX analyzer. In the 
baseline/fasting blood sample only, hemoglobin A1C (HbA1c) was measured in whole blood via 
DCA Vantage analyzer (DCA Vantage Analyzer; Boston, MA, USA). 
Vascular Function 
Vascular function was assessed using FMD. This technique incorporates temporary distal 
occlusion of a limb to elicit a dilatory response. This experiment used the brachial artery for the 
dilatory examination and the wrist as the distal occlusion site. Participants were instructed to lie 
in a supine position for 15 minutes in a darkened area to normalize to the room conditions. 
Afterward, the individual extended their arm into a cradle to gain a longitudinal view of the 
brachial artery with a Doppler ultrasound and a 12 MHz probe (Mindray Z5 Ultrasound System; 
Mindray North America). Video feedback was transposed to a local computer via HDMI video 
converter (AV.io HD; Epiphan). A blood pressure cuff was placed distally on the wrist, and initial 
baseline video of the brachial artery was recorded for 2 minutes. After the baseline recording, an 
occlusion pressure of 50 mmHg greater than the participant’s systolic blood pressure was applied 
for 4 minutes. The pressure was then released, and video of the brachial artery hyperemic 
response was recorded for an additional 4 minutes. A total of 10 minutes of video recording was 
collected for each FMD analysis (i.e. 2 minutes baselines, 4 minutes occlusion, 4 minutes post-




diameter continuously during recorded videos (CardioSuite, Quipu; Pisa, IT). The FMD was 
reported as the percentage change (%) in brachial artery diameter from baseline to the maximum 
dilation after cuff pressure is released. FMD was conducted at baseline (fasting), 2 hour, and 4 
hour post-HFM (Fig. 1).  
Statistical Analyses 
Using mean differences and standard deviations from a previous cross-sectional study 
from our laboratory (Emerson et al. 2018), we estimated that at least 6 individuals per group 
would be necessary to detect differences in TG total area under the curve (tAUC). In this prior 
study, we detected significant group differences with n = 7-8 per group. With regard to vascular 
function, we selected a minimum necessary difference (between groups or in response to the 
meal) of 4% for FMD with an estimated standard deviation of 2% based on previous studies 
(Pierce et al. 2011; Marchesi et al. 2000). This calculation estimated a minimum necessary 
sample size of n = 7 per group. To be conservative, we aimed to recruit n = 7-10 participants per 
group. For the metabolic outcomes, we calculated tAUC, incremental area under the curve 
(iAUC) responses, and the metabolic load index (MLI). The tAUC represents the total response 
for the entire 6-hour postprandial period, while the iAUC response represents the total relative 
change from baseline/fasting during the postprandial period. The MLI represents a summative 
glycemic and lipemic value and was calculated by adding together the TG and glucose together. 
We also determined the peak concentration for each metabolic outcome, as well as the time in the 
postprandial period at which the peak occurred. A one-way analysis of variance (ANOVA) to 
determine group differences in participant characteristics, fasting metabolic values peak, time to 
peak, tAUC, and iAUC. For metabolic outcomes and FMD, a two-way (group × time) repeated-
measures ANOVA was used to test for time-course interactions between groups in the 
postprandial period. Tukey’s post hoc adjustment was utilized if main group effects were found. 




La Jolla, CA). We also conducted a partial correlation analysis of body composition and glucose 
control (HbA1c) with metabolic and vascular outcomes while controlling for age and physical 
activity (steps/day) in SPSS (IBM Corp, SPSS Statistics for Windows, Version 24.0; Armonk, 
NY). Values were considered statistically significant at p < 0.05 for all of the analyses conducted 










Participant characteristics are shown in Table 1. Significant group effects were observed 
for age, BMI, body fat percentage, visceral adipose tissue, and HbA1c. YA and YI were 
significantly younger than OA and OI (YA vs OA: p < 0.0001; YA vs OI: p < 0.0001; YI vs OA: 
p < 0.0001; YI vs OA: p < 0.0001). There was no significant difference in age between YA and 
YI (p = 0.99) or OA and OI (p = 0.99). YA had significantly lower BMI compared to OI (p = 
0.007). There were no other significant differences between groups with regard to BMI (YA vs 
YI: p = 0.73; YA vs OA: p = 0.10; YI vs OA: p = 0.55; YI vs OI: p = 0.09; OA vs OI: p = 0.65). 
Body fat percentage was significantly different between groups, wherein YA had a lower body fat 
percentage compared to OA (Mean diff: -12.70; 95% CI: -19.75 to -5.64; p = 0.0002) and OI 
(Mean diff: -17.78; 95% CI: -25.09 to -10.47; p < 0.0001); YI had a lower body fat percentage 
than OA (Mean diff: -8.91; 95% CI: -16.42 to -1.40; p = 0.02) and OI (Mean diff: -17.78; 95% 
CI: -25.09 to -10.47; p = 0.0002). There were no significant differences in body fat percentage 
between YA vs YI (p = 0.50) or OA vs OI (p = 0.27). These findings were similar when 
comparing the differences in visceral adipose tissue between groups. YA was lower than OA 
(Mean diff: -0.96; 95% CI: -1.91 to -0.01; p = 0.04) and OI (Mean diff: -1.68; 95% CI: -0.69 to 




There were no significant differences in visceral adipose tissue between YA vs YI (p = 
0.98), YI vs OA (p = 0.11), or OA vs OI (p  = 0.23). Skeletal muscle mass did not differ between 
groups (p = 0.85). There was a significant group effect for HbA1c, where YI was lower than OA 
(Mean diff: -0.54; 95% CI: -0.97 to -0.12; p = 0.009) and OI (Mean diff: -0.44; 95% CI: -0.88 to 
0.0; p = 0.048). There were no other significant differences between groups in HbA1c (YA vs YI: 
p = 0.51; YA vs OA: p = 0.13; YA vs OI: p = 0.44; OA vs OI: p = 0.91). The test meal energy 
(kcal) did not significantly differ between groups (p = 0.11). 
 Physical activity level, measured in steps per day, was significantly different between 
groups, where the active groups had significantly higher steps per day than the inactive groups. 
The YA was more active than YI (p = 0.03); YA was more active than OI (p = 0.03); and OA was 
more active than OI (p = 0.0495). There were no other significant group differences in steps/day 
(YI vs OA: p = 0.06; YA vs OA: p = 0.87; YI vs OI: p = 0.87). 
Fasting metabolic outcomes 
Fasting metabolic outcomes are shown in Table 2. There were no significant differences 
in fasting TG between YA vs YI (p = 0.09), YA vs OA (p = 0.97), YA vs OI (p = 0.21), YI vs OI 
(p = 0.99), or OA vs OI (p = 0.11). However, YI had significantly higher fasting TG than OA (p = 
0.04). Two participants were found to have fasting TG >150 mg/dL fasting (1 YI and 1 OI). 
There were no significant differences between groups for fasting glucose (p = 0.32). There was a 
significant group effect with fasting MLI (p = 0.02), but no significant differences between 
groups were found with post hoc comparisons. A significant group effect was observed for 
fasting Total-C (p = 0.03). Fasting Total-C was significantly lower in YA compared to OI (p = 
0.02); however, no significant differences were found in fasting Total-C when comparing YA vs 
YI (p = 0.70), YA vs OA (p = 0.44), YI vs OA (p = 0.98), YI vs OI (p = 0.17), or OA vs OI (p = 
0.33). There were 11 individuals that had fasting Total-C >200 mg/dL (1 YA, 2 YI, 3 OA, and 5 




lower fasting LDL-C compared to OI (p = 0.01). Fasting LDL-C was not significantly different in 
YA vs YI (p = 0.81), YA vs OA (p = 0.61), YI vs OI (p = 0.07), YI vs OA (p = 0.99), or OA vs 
OI (p = 0.14). There were no differences between groups in fasting HDL-C (p = 0.99). Despite 
this, there were 5 individuals (3 YA, 1 YI, and 1 OA) that presented with HDL-C <40 mg/dL. 
Postprandial metabolic responses 
Postprandial metabolic outcomes are presented in Table 3. There was a significant group 
× time interaction for the postprandial TG response (p < 0.0001). YA had a significantly lower 
TG peak compared to YI (p = 0.02) and OI (p = 0.02). Similarly, OA had a lower TG peak 
compared to YI (p = 0.03) and OI (p = 0.02). There were no significant differences in peak TG 
for YA vs OA (p = 0.99) or YI vs OI (p = 0.99). The TG time to peak was significantly different 
between groups (p = 0.02), but there were no significant post hoc comparisons between groups. 
TG tAUC was significantly different in YA vs YI (p = 0.007), YA vs OI (p = 0.004), YA vs OA 
(p = 0.01), and OA vs OI (p = 0.008). However, there were no significant differences in TG 
tAUC comparing YA vs OA (p = 0.99) or YI vs OI (p = 0.99). TG iAUC was significantly lower 
in YA vs YI (p = 0.02), YA vs OI (p = 0.005), and OA vs OI (p = 0.03). TG iAUC was not 
statistically different comparing YA vs OA (p = 0.92), YI vs OA (p = 0.11), or YI vs OI (p = 
0.89).  
 The postprandial glucose response did not exhibit a significant group × time interaction 
(p = 0.59) or time effect (p = 0.18) during the postprandial period. However, there was a 
significant group effect (p = 0.007). Specifically, YA was lower than OA (p = 0.04) and OI (p = 
0.01) across the entire postprandial period. There were no significant differences in peak glucose 
responses (p = 0.05), time to peak (p = 0.71), or glucose iAUC (p = 0.09). YA had a significant 
lower glucose tAUC compared to OA (p = 0.04) and OI (p = 0.01). There were no other 
significant differences in glucose tAUC (YA vs YI: p = 0.69; YI vs OA: p = 0.37; YI vs OI: p = 




 MLI exhibited a significant group × time interaction (p < 0.0001). YA had a significantly 
lower peak compared to YI (p = 0.01) and OI (p = 0.005). OA had a significantly lower peak 
response compared to OI (p = 0.02) and YI (p = 0.049). MLI time to peak did not differ between 
groups. There were no significant differences in peak MLI responses comparing YA vs OA (p = 
0.97) or YI vs OI (p = 0.95). The MLI tAUC was significantly lower in YA vs YI (p = 0.005), 
YA vs OI (p = 0.001), and OA vs OI (p = 0.008). YI had a significantly higher MLI tAUC 
compared to OA (p = 0.03). The MLI tAUC responses did not differ comparing YA vs OA (p = 
0.90) or YI vs OI (p = 0.90). The MLI iAUC was lower in YA vs YI (p = 0.01), YA vs OI (p = 
0.001), and OA vs OI (p = 0.02). There were no significant differences in MLI iAUC for YA vs 
OA (p = 0.64), YI vs OI (p = 0.74), or YI vs OA (p = 0.16).  
 There was no significant group × time interaction for postprandial Total-C (p = 0.07). 
However, there were significant time (p = 0.04) and group (p = 0.01) effects. Peak Total-C was 
significantly lower in YA compared to OI (p = 0.007). There were no other significant differences 
in Total-C time to peak. There were no significant differences in peak Total-C comparing YA vs 
YI (p = 0.51), YA vs OA (p = 0.57), YI vs OA (p = 0.99), YI vs OI (p = 0.16), or OA vs OI (p = 
0.13). Total-C tAUC was significantly lower in YA vs OI (p = 0.006). No significant 
comparisons were found between YA vs YI (p = 0.49), YA vs OA (p = 0.53), YI vs OA (p = 
0.99), YI vs OI (p = 0.16), or OA vs OI (p = 0.14). The Total-C iAUC was not significantly 
different between groups. Total-C time to peak was lower in the OA compared to OI (p = 0.005).  
 There was no group × time interaction detected in postprandial LDL-C (p = 0.74), 
although there were significant time (p = 0.002) and group (p = 0.009) effects. YA had a 
significantly lower peak postprandial LDL-C compared to OI (p = 0.008). However, there were 
no significant group differences in LDL-C time to peak. Moreover, there were no significant 
differences between YA vs YI (p = 0.57), YA vs OA (p = 0.21), YI vs OA (p = 0.90), YI vs OI (p 




comparisons were found between YA vs YI (p = 0.27), YA vs OA (p = 0.27), YI vs OA (p = 
0.84), YI vs OI (p = 0.07), or OA vs OI (p = 0.32). There were no significant group differences in 
LDL-C iAUC. 
 Regarding HDL-C, two-way repeated measures ANOVA revealed no significant group × 
interaction (p = 0.43), time effect (p = 0.21), or group effect (p = 0.98). There were no significant 
differences in HDL-C peak, time to peak, tAUC, or iAUC. 
Vascular function 
Postprandial vascular function is shown in Figure 4. A one-way ANOVA detected a 
significant difference between groups in BL (Baseline) FMD (p = 0.002). YA exhibited 
significantly greater FMD compared to YI (Mean Diff: 2.38; 95% CI: 0.37 to 4.40; p = 0.02) and 
OI (Mean Diff: 3.09; 95% CI: 1.00 to 5.17; p = 0.002). There were no significant differences in 
BL FMD comparing YA vs OA (Mean Diff: 1.54; 95% CI: -0.47 to 3.55; p = 0.18), YI vs OA 
(Mean Diff: -0.84; 95% CI: -2.92 to 1.23; p = 0.67), YI vs OI (Mean Diff: 0.70; 95% CI: -1.44 to 
2.85; p = 0.81), or OA vs OI (Mean Diff: 1.55; 95% CI: -0.60 to 3.69; p = 0.22).   
In the postprandial period, there was no significant group × time interaction (p = 0.08) or 
group effect (p = 0.06), although there was a significant time effect (p = 0.008). When analyzing 
all groups together, there was a significant decrease in FMD from BL to 4th hour (Mean Diff: 
1.19; 95% CI: 0.27 to 2.11; p = 0.008). YA had a significantly decreased FMD from BL to 4th 
hour post-meal (Mean Diff: 2.54; 95% CI: 0.82 to 4.25; p = 0.02). However, there were no 
significant differences in YA FMD comparing BL vs 2nd hour FMD (Mean Diff: 1.69; 95% CI: -
0.08 to 3.46; p = 0.06) or 2nd hour vs 4th hour (Mean Diff: 0.84; 95% CI: -0.93 to 2.61; p = 0.49). 
YI had no significant differences in FMD between any two-time points. OA FMD significantly 
decreased at 2nd hour compared to BL (Mean Diff: 1.89; 95% CI: 0.08 to 3.7; p = 0.04). There 




0.13 to 3.65; p = 0.07) or 2nd hour vs 4th hour (Mean Diff: -0.13; 95% CI: -2.03 to 1.76; p = 0.98). 
The OI had no significant differences in FMD between any two-time points.  
Associations with body composition and HbA1c 
Associations between primary outcomes and body composition and HbA1C are found in 
Table 4. After controlling for physical activity (steps/day) and age, there was a significant 
negative correlation between body fat % (BF) and BL FMD (r = -0.50; p = 0.007). Visceral 
adipose tissue (VAT) was positively associated with peak TG (r = 0.43; p = 0.02), TG tAUC (r = 
0.38; p = 0.04), TG iAUC (r = 0.50; p = 0.005), MLI peak (r = 0.44; p = 0.02), MLI tAUC (r = 
0.39; p = 0.03), and MLI iAUC (r = 0.50; p = 0.006). Skeletal muscle mass (SMM) was 
positively associated with MLI iAUC (r = 0.43; p = 0.02). HbA1C was not correlated with any 









The primary aim of this study was to determine the independent effects of age and 
physical activity on postprandial metabolic markers and vascular function. The data partially 
supported our hypothesis that younger and more active individuals would experience an 
attenuated TG response compared to older less active individuals. The postprandial TG responses 
for the active groups (YA vs OA) were not different, nor were those of the inactive groups (YI vs 
OI). This finding suggests that physical activity may be a more influential modifier of PPL 
responses than age. With regard to vascular function, there were distinct differences in baseline 
vascular function, where YA individuals exhibited higher FMD compared to the inactive groups. 
We observed a significant reduction in FMD across groups 4 hours after the HFM; however, we 
did not find group differences in postprandial vascular function. Lastly, we found that PPL was 
correlated with some but not all components of body composition. 
Postprandial Metabolic Markers  
Previous literature has demonstrated the negative implications of elevated postprandial 
TG in relation to CVD risk (Nordestgaard and Varbo 2014; McBride 2007; Hokanson 1998). 
Specifically, postprandial TG have been shown to be more predictive of CVD risk than traditional 
fasting values (Bansal et al. 2008). After the consumption of a meal, the body enters an acute 




prolonged concentrations of these markers can induce physiological damage. Namely, the period 
of elevated TG following a meal known as PPL is associated with endothelial dysfunction, 
inflammation, and oxidative damage. Individuals typically consume meals frequently throughout 
the day, making PPL a physiologically relevant measurement for CVD risk. 
 Several studies have separately examined the impact of age and physical activity on 
postprandial TG (Altena et al. 2004; Cassader et al. 1996). Acute exercise prior to a HFM (i.e. 
24-48 hours prior) can blunt postprandial TG (Zhang and Nunez 2006). Exercise can acutely 
increase lipoprotein lipase (LPL) activity, which removes TG from very-low-density lipoprotein 
(VLDL) and chylomicron (CM) particles (Al-Shayji et al. 2011). After exercise, LPL activity 
remains elevated in skeletal muscle, allowing for improved lipid clearance after a meal (Zderic 
and Hamilton 2006; Zhang et al. 2002). However, LPL activity typically peaks between 4 and 18 
hours following acute exercise (Peddie et al. 2012). In the present study, participants avoided 
exercise for 48 hours prior to the HFM. Therefore, it is unlikely that enhanced LPL activity is the 
explanation for group differences in PPL in our study.  Habitual physical activity can also exert a 
beneficial impact on PPL. In addition to increased LPL activity, habitual exercise has the 
potential to induce body composition changes that are beneficial for the reduction in PPL. More 
specifically, exercise can reduce body fat and increase levels of skeletal muscle mass, which can 
reduce the magnitude and duration of PPL (Geer et al. 2009). Lastly, overtime physical activity 
can help create a caloric deficit, which also can reduce PPL (Malkova et al. 2006). 
There is clear evidence supporting the notion that older individuals exhibit an 
exaggerated PPL compared to younger individuals (Cohn et al. 1988). There is some speculation 
that age-related decline in gastric emptying results in an exaggerated PPL response. However, 
one of the most well-studied contributors to increased PPL is the reduction in CM clearance 
capacity. This decrease in CM clearance is thought to be a product of the age-related reduction of 




exercise can become more challenging, increasing the likelihood of negative body composition 
changes such as a loss of muscle mass, increase in body fat percentage, increase in visceral 
adiposity, and an increase in liver steatosis. Together, a reduction in skeletal muscle mass and 
increased fat deposits have been associated with elevated PPL (Herd et al. 2001). In the present 
study, there were no differences in skeletal muscle mass between groups, although there were 
large differences in postprandial TG responses. 
 Elevated visceral fat is associated with insulin resistance and dyslipidemia, causing 
exaggerated postprandial responses and, ultimately, an increased risk of CVD (Jensen et al. 2008; 
Banerji et al. 1999). In a study conducted by Couillard and colleagues (1998), the relationship 
between PPL and body composition was assessed in obese men after the consumption of a HFM 
(n = 43). Interestingly, they found a stronger positive relationship between VAT and tAUC TG (r 
= 0.45; p < 0.01) compared to BF (r = 0.40; p < 0.01). We assessed these associations in the 
present study by examining the relationship between body composition and postprandial 
responses. Our data partially supports this relationship, as we found a significant positive 
correlation between VAT and numerous PPL indices across our total sample. On the other hand, 
BF and VAT were greatly different between groups, where the older individuals had a 
significantly higher visceral fat content compared to the younger groups. Despite these stark 
differences, both the younger and older active groups sustained an attenuated PPL response. Also, 
BF was not associated with any PPL indices. Taken together, our findings suggest that body 
composition likely explains some, but not all, of the variation in PPL due to age and physical 
activity status.  
Postprandial glucose was not different between groups, with the exception of a few 
significant post hoc comparisons. The lack of group differences in postprandial glycemia was not 
surprising, given that the composition of the meal (63% fat and 34% carbohydrate) was designed 




differences in PPL could be explained by variations in HbA1c, an indicator of long-term glucose 
control. Older and less active individuals tend to have worse insulin sensitivity than younger and 
more active counterparts (Amati et al. 2009). Regular physical activity has been shown to 
improve insulin sensitivity. Therefore, differences in insulin sensitivity due to aging and/or 
physical activity have been suggested as a determinant of PPL (Guerci et al. 2000). However, 
despite substantial differences in PPL, groups did not differ in HbA1c. Additionally, there was no 
correlation between HbA1C and any of the postprandial metabolic outcomes after controlling for 
age and physical activity level, suggesting that glucose control is not the sole driver of group 
differences in PPL. However, this data is limited in that it utilized HbA1c as a measure of glucose 
control rather than measuring insulin sensitivity directly. 
MLI provides a summation of both glucose and TG responses and is intended to represent 
the total metabolic challenge induced by a mixed meal (Emerson et al. 2016). Both elevated 
levels of glucose and TG are associated with increased CVD risk making this metric relevant to 
the prediction of CVD (Ceriello et al. 2006; Lefebvre and Scheen 1998). MLI was lower in the 
more active individuals compared to the inactive, regardless of age. Despite the relatively little 
change in postprandial glucose, group differences in MLI were anticipated given the large 
differences in TG responses. This further demonstrates the differences in postprandial metabolism 
between groups and supports our expectation that there would be a reduced metabolic clearance 
capacity in older and less active individuals.  
Many studies have found Total-C and LDL-C to increase with age and inactivity (Félix-
Redondo et al. 2013; Mora et al. 2006). Supporting this notion, Total-C was highest in OI. 
However, due to the latency of this biomarker to change, large changes in postprandial Total-C 
are not commonly seen. This concept was supported by our results, where no time effect 
throughout the postprandial period was observed. Similarly, there were no significant 




LDL-C remained relatively stable in the postprandial period across groups. Despite the lack of 
acute postprandial differences between groups, Total-C is largely dependent upon age and 
physical inactivity. Supporting this notion, Total-C was significantly lower in the younger and 
more active groups in this study.  HDL-C exerts highly anti-atherogenic properties and has been 
reported to increase in individuals exhibiting beneficial lifestyle patterns, namely high physical 
activity (Barter et al. 2011; Skoumas et al. 2003). Most notably, HDL-C exerts its beneficial 
effects by playing an integral role in reverse cholesterol transport. HDL-C promotes the efflux of 
cholesterol from peripheral cells and then facilitates transportation to the liver for re-use or 
excretion. Given the role of peripheral cholesterol in plaque development, HDL-C plays an 
important role in CVD prevention (Filippatos et al. 2013). However, we found no differences in 
HDL-C between groups in this study, nor were there any changes or group differences in the 
postprandial period. 
Vascular Function 
Vascular function is highly regarded as a predictor for CVD (Verma et al. 2003). More 
specifically, vasodilation reflects the functional ability of the endothelium to supply peripheral 
tissues with nutrients and oxygen. As we age, the body undergoes a variety of changes that reduce 
the functional capacity of the endothelium to dilate and constrict. This includes changes such as 
an increase in oxidative stress, reduced nitric oxide bioavailability, and an increase in 
vasoconstrictive compounds, which impair adequate vessel dilation (Gerhard et al. 1996). Over 
time, these detrimental changes can elicit negative structural changes within the vasculature 
including vessel stiffening, promotion of plaque development, and a reduced endothelial repairing 
capacity (Cheng et al. 2017). According to Celermajer et al. (1994), age-related vascular decline 
begins affecting male individuals > 40 years of age at a rate of 0.21% reduction in FMD per year. 
Interestingly, this age-related decline was preserved in women and did not begin declining until 




this age-related decline in endothelial function (Black et al. 2008). It has been proposed that 
exercise can improve vasodilation via the upregulation of NO-synthase, vascular endothelial 
growth factors (VEGF), and proangiogenic factors (Hoier et al. 2014). Lastly, exercise promotes 
physiological protective mechanisms against free radical damage by increasing the function of 
antioxidative cellular mechanisms (Radak et al. 2008).  
Vascular function has also been observed to decrease in response to a HFM (Ceriello et 
al. 2002; Kawano et al. 1999). The PPL that acutely follows the consumption of a HFM evokes 
an enormous amount of free radical production. PPL initiates an influx of free fatty acids (FFA), 
ultimately producing large amounts of acetyl-coA. This rapid influx of acetyl-coA creates an 
overabundance of electron donors (e.g. NADH/FADH2) promoting free radical production. NO 
acts as a prevalent electron acceptor leading to a reduction in bioavailability during the 
postprandial period (Wallace et al. 2010). NO plays a crucial role in vasodilation, thus during 
times of reduced bioavailability have a negative impact on vascular function. In the present study, 
serum TG levels were significantly correlated with FMD responses, suggesting a strong 
connection between PPL and FMD. This relationship between PPL and FMD was partially 
supported by our findings, as all groups experienced a decrease in vascular function after the 
HFM. Most notably, FMD reduction was more pronounced in the active groups. However, group 
differences in FMD during the postprandial period were not as large or distinct as those for PPL. 
The greater decreases in vascular function observed in the active individuals could be explained 
by a higher degree of function before the consumption of the HFM. Similarly, the lack of change 
in older and less active individuals might be due to pre-existing, lower vascular function prior to 
the HFM. This low baseline FMD may have also influenced the ability to detect group differences 
in the postprandial period.  
Body composition also plays an important role in vascular function. This has been 




al. 2017; Parikh et al. 2009). As BF increases, concomitant increases can be found in 
inflammatory cytokines, insulin resistance, and reduction in adiponectin. Together, these changes 
in physiological function can exert negative effects on endothelial function. The primary 
mechanism is thought to be a product of insulin resistance that is often prevalent in individuals 
with greater degrees of adiposity. Insulin generally has a positive effect on vasodilation, 
improving blood flow in a healthy individual. However, in disrupted metabolic states such as 
insulin resistance, the endothelial insulin NO mechanism becomes ineffective ultimately leading 
to a lack of vasodilation in postprandial periods (Steinberg et al. 1996). Additionally, insulin 
resistance leads to increased serum glucose levels which can promote oxidative stress, further 
impairing vasodilation. Interestingly, there was a significant association between BF and FMD; 
however, unlike PPL there was no association between VAT and FMD. Body composition was 
able to explain some, but not all of the postprandial metabolic and vascular responses. 
Strengths and Limitations 
The present study contains several strengths and limitations that should be considered 
when interpreting findings. Notably, a strength of this study was the frequent measurement of 
metabolic outcomes. The TG response can essentially be captured with a single blood draw 4-
hours post-HFM (Sciarrillo et al. 2019); however, we were able to more thoroughly capture this 
response in the present study via serial blood draws for 6 hours. Next, our prohibition of exercise 
for 48 hours prior to the HFM removed the potential confounding effects of recent exercise, 
thereby better allowing us to test the effects of regular physical activity. Lastly, some postprandial 
studies have used mixed meals that are unreflective of the caloric density common in a western 
diet meal. On the other hand, the present study used a realistic western meal with energy and fat 




In this study, individuals were excluded if they were taking blood pressure- and lipid-
lowering medications, since our primary outcomes were postprandial lipids and vascular function. 
However, this exclusion criterion likely limits the applicability of our data, especially within the 
older population. Regarding vascular function, we only measured FMD at BL, 2 hours, and 4 
hours post-HFM, which may have not fully captured postprandial vascular changes. Finally, our 
groups did not have identical distributions of men and women, possibly introducing error into 
group comparisons and precluding the opportunity to analyze possible sex differences within our 
sample.  
CONCLUSION 
This study aimed to determine differences in postprandial metabolic and vascular 
outcomes in groups that differed by age and physical activity level, as well as explore factors that 
may explain group differences. Our data speaks to the importance of physical activity in 
mediating TG responses to a HFM, which directly corresponds to the risk of CVD development. 
Moreover, the OA adults in our study exhibited a nearly identical PPL response to YA adults, 
suggesting that physical activity level is more important in modifying PPL than age per se. With 
regard to vascular function, we observed HFM-induced decrements in FMD that were primarily 
observed in active individuals. We found that younger active individuals had the highest degree 
of vascular function in the fasting state compared to inactive individuals. However, further 
elucidation of mechanisms involved in the reduced baseline function seen in the older and less 
active population is greatly needed for understanding the preservation of vascular function with 
aging. Additionally, the original design of the study controlled for sex differences; however, few 
studies have examined the differential impact of sex across the lifespan while also considering 
physical activity. Our data also suggest that body composition, specifically visceral fat and SMM, 
are associated with the PPL response regardless of age and physical activity level, while BF was 




differences in our study. Therefore, future studies should further investigate other physiological 






Table 1. Participant characteristics. Normally distributed data are displayed as Mean ± SD and 
non-normally distributed data are displayed as Median (Interquartile Range). Within main effects 
(by row), values with shared superscript letters are not significantly different, determined by post 
hoc pairwise comparison. Rows with no superscript letters present contain no significant 
differences. See Results section for post hoc pairwise comparison p-values. n, number of 























Sex 4F/5M 3F/5M 4F/4M 5F/2M 
 
Age (years) 22.1 ± 1.4a 22.6 ± 3.7a 68.4 ± 7.7b 67.7 ± 7.2b <0.0001 
BMI (kg/m2) 23.8 ± 2.7a 25.7 ± 3.7ab 28.2 ± 3.4ab 30.4 ± 4.9b 0.008 
Body fat (% total mass) 15.1 ± 4.6a 18.9 ± 2.8a 27.8 ± 7.1b 32.87 ± 5.7b <0.0001 
Visceral Adipose 
Tissue (kg) 
0.48 ± 0.37a 0.61 ± 0.55a 1.44 ± 0.59b 2.16 ± 1.20b 0.0002 
Skeletal Muscle Mass 
(kg) 
26.9 ± 6.4 24.9 ± 11.3 24.0 ± 5.3 23.8 ± 8.6 0.85 
HbA1c (%) 5.36 ± 0.25ab 5.14 ± 0.36a 5.69 ± 0.24b 5.51 ± 0.39ab 0.008 
Steps/day 12935 ± 3216a 8498 ± 2655bc 12232 ± 3373ab 8059 ± 2719c 0.005 





Table 2. Fasting Metabolic Values. Normally distributed data are displayed as Mean ± SD, and 
non-normally distributed data are displayed as Median (Interquartile Range). A one-way ANOVA 
was conducted to test for differences between groups. Within main effects (by row), values with 
shared superscript letters are not significantly different, determined by post hoc pairwise 
comparison. Rows with no superscript letters present contain no significant differences. See 
Results section for post hoc pairwise comparison p-values; TG, triglycerides; GLU, glucose; 
MLI, metabolic load index; Total-C, total cholesterol; LDL-C, low-density lipoprotein 
cholesterol; HDL-C, high-density lipoprotein cholesterol.  
 

















TG <150 65.1 ± 16.6ab 96.4 ± 46.3a 59.4 ± 15.6b 91.7 ± 10.5ab 0.02 
GLU <100 85.8 ± 3.8 85.3 ± 6.1 89.1 ± 9.7 90.4 ± 4.1 0.32 
MLI N/A 150.9 ± 17.3 181.6 ± 45.3 148.5 ± 21.1 182.1 ± 12.2 0.02 
Total-C <200 150.1 ± 28.1a 169.1 ± 45.5ab 176.5 ± 39.0ab 208.7 ± 27.8b 0.03 
LDL-C <100 85.1 ± 22.1a 98.1 ± 30.2ab 103.3 ± 36.9ab 137.7 ± 31.0b 0.01 




Table 3. Postprandial Metabolic Outcomes. Normally distributed data are displayed as Mean ± 
SD and non-normally distributed data are displayed as Median (Interquartile Range). A one-way 
ANOVA for parametric data and a Kruskal-Wallis test for non-parametric data were conducted to 
test for differences between groups. The p-value column denotes main effects between groups 
assessed via one-way ANOVA or Kruskal-Wallis. Within main effects (by row), values with 
shared superscript letters are not significantly different, determined by post hoc pairwise 
comparisons. Rows with no superscript letters present contain no significant differences. See 
Results section for post hoc pairwise comparison p-values. tAUC, total area under the curve; 
iAUC, incremental area under the curve; incremental area under the curve; LDL, low-density 






Table 4. Partial Correlation of Body Composition and Glucose Control with Metabolic and 
Vascular Outcomes. A partial correlation was utilized to determine the association between 
body composition variables and HbA1c (surrogate of glucose control) with postprandial TG, 
MLI, and baseline FMD while controlling for physical activity (steps per day) and age. The r row 
represents the partial correlation coefficient and the P row represents the P-value for the 
correlation. TG, triglycerides; tAUC, total area under the curve; iAUC, incremental area under 
the curve; MLI, metabolic load index; FMD, flow-mediated dilation; BF, body fat percentage; 
VAT, visceral adiposity tissue; SMM, skeletal muscle mass; HbA1C, hemoglobin A1C. 
 
 







Figure 2. Postprandial Responses for Triglycerides, Glucose, and Metabolic Load Index. 
Triglycerides, glucose, and the metabolic load index were assessed at baseline/fasting (time 0) 
and serially for six hours after the high-fat meal. Significant differences (p < 0.05) at specific 
time-points reflect the results of a two-way (group × time) repeated measures ANOVA. Error 
bars reflect standard error of mean (SEM). ∂ YA vs OA, # YA vs OI, + YI vs OI, ◊ OA vs OI, Λ 






Figure 3. Postprandial Cholesterol Responses. Total cholesterol, LDL-C, and HDL-C were 
assessed at baseline/fasting (time 0) and serially for six hours after the high-fat meal. Significant 
differences (p < 0.05) at specific time-points reflect the results of a two-way (group x time) 
repeated measures ANOVA. Error bars reflect standard error of mean (SEM). ∂ YA vs OA, # YA 
vs OI, + YI vs OI, ◊ OA vs OI, Λ YA vs YI, *YI vs OA. YA, younger active adults; OA, older 
active adults; OI, older inactive adults. Total-C, total cholesterol; LDL-C, total cholesterol; LDL-






Figure 4. Postprandial Vascular Function. Flow-mediated dilation was measured at 
baseline/fasting, 2 hours, and 4 hours after the high-fat meal. Significant differences (p < 0.05) at 
specific time-points reflect the results of a two-way (group x time) repeated measures ANOVA. 
Error bars reflect standard error of mean (SEM). ∂ YA vs OA, # YA vs OI, + YI vs OI, ◊ OA vs 
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